首页> 美国卫生研究院文献>Journal of Hematology Oncology >Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

【2h】

Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

机译：与强化化疗相比阿扎胞苷在较年长的AML患者亚组中可能有益：一项针对227位连续患者的单中心回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTreatment options in older acute myeloid leukaemia (AML) patients include intensive chemotherapy, best supportive care (BSC), and hypomethylating agents. Currently, limited data is available on hypomethylating agents in older AML patients in unselected patient populations.

机译：背景老年急性髓细胞性白血病（AML）患者的治疗选择包括强化化疗，最佳支持治疗（BSC）和低甲基化药物。当前，关于未选患者群体中老年AML患者低甲基化药物的可用数据有限。

著录项

期刊名称 Journal of Hematology Oncology
作者
Lieke H van der Helm; Ellen RM Scheepers; Nic JGM Veeger; Simon MGJ Daenen; André B Mulder; Eva van den Berg; Edo Vellenga; Gerwin Huls;
展开▼
作者单位

展开▼
年(卷),期 2013(6),-1
年度 2013
页码 29
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;血液学检验;
关键词
Acute myeloid leukaemia Older age Azacitidine Intensive chemotherapy Best supportive care;

机译：急性髓细胞性白血病;高龄;阿扎胞苷;强化化疗;最佳支持治疗;

相似文献

外文文献
中文文献
专利

1. Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients [J] . Lieke H van der Helm, Ellen RM Scheepers, Nic JGM Veeger, Journal of Hematology and Oncology . 2013,第S1期

机译：与强化化疗相比，阿扎胞苷在较年长的AML患者亚组中可能有益：一项对227位连续患者进行的单中心回顾性研究
2. Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3(mut+)) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort [J] . Esteve Jordi, Schots Rik, Del Castillo Teresa Bernal, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：多中心，开放标签，3臂研究Gilteritinib，Gilteritinib加氮杂氨酸，或仅在新诊断的FLT3突变（FLT3（MUT +））急性髓性白血病（AML）患者中没有资格对强化诱导化疗的患者：从安全队列中发现
3. Assesment of Frailty Scores Validating Fitness of Elderly AML Patients for Intensive Chemotherapy: A Single Centre Study [J] . Aydin Semra, Franzino Marco, Frairia Chiara, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：评估验证老年人AML患者的体育患者的体积分数：单一中心研究
4. Incidence of inhibitor Dewelopment in consecutiwely recruited sewere Hemophilia A and B Patients - a retrospective Single Centre Study [C] . S. Halimeh, A. Kosch, N. Bgsdanova, Hemophilie-Symposion . 2003

机译：抑制剂发育的发病率在连续招募苏抚血友病A和B患者 - 一个回顾性单一中心研究
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study [O] . A. Schauwvlieghe, A. Dunbar, E. Storme, 2021

机译：在AML / MDS强化化疗后在患有Febrile Neveropenia患者的72小时后停止抗生素治疗（安全研究）：回顾性比较队列研究
7. Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy:a single centre retrospective study of 227 consecutive patients [O] . van der Helm Lieke H, Scheepers Ellen R M, Veeger Nic J G M, 2013

机译：与强化化疗相比，阿扎胞苷在老年AML患者亚组中可能是有益的：一项针对227位连续患者的单中心回顾性研究

Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

摘要

著录项

相似文献

相关主题

期刊订阅